Xarelto Lawsuit Claims Center
Have you or a loved one taken the prescription drug Xarelto
and suffered serious life threatening complications?
Complications from Xarelto include internal bleeding,
pulmonary embolism, deep vein thrombosis, and death.
Promise to our clients: No Recovery; No Fees.
Xarelto Lawsuit Information Center
With the medical community buzzing about a new-generation blood thinner that may be tied to life-threatening internal bleeding injuries, you’d be right to consider a Xarelto lawsuit if you or someone close to you were seriously harmed by this medication.
A number of claims involving the medication, which was approved in 2011 to reduce the risk of blood clots in patients undergoing hip replacement surgeries and is now frequently prescribed in the treatment of deep vein thrombosis, pulmonary embolism and patients with atrial fibrillation, have been filed by individuals who allege life-threatening episodes of internal bleeding, in addition to several other serious side effects. Over the past three years, Xarelto has also been named in thousands of adverse event reports filed with the U.S. Food and Drug Administration (FDA).
If you or a loved one suffered life-threatening episodes of internal bleeding, pulmonary embolism, deep vein thrombosis, or another injury that may have resulted in death, the time is now to call our Firm. The attorneys at Bernstein Liebhard LLP can explain the differences between filing a Xarelto class action lawsuit, which involves multiple plaintiffs included in a single case, and an individual claim, where there is only one.
What is Xarelto?
Xarelto is known in its generic form as rivoxaban, and is part of a new class of blood thinners known as direct thrombin inhibitors that also includes Pradaxa and Eliquis.
Marketed jointly by Bayer HealthCare and the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, this medication is currently approved for the following uses:
- Reduce the risk of blood clots in patients undergoing hip replacement surgeries
- Prevent blood clots in patients with atrial fibrillation
- Treatment of deep vein thrombosis and pulmonary embolism
Just two years after Xarelto appeared on the market, the blood thinner achieved blockbuster status in earning $1.3 billion global sales for 2013.
Xarelto’s manufacturer has long touted its benefits over warfarin, a decades-old blood thinner that requires routine medical check-ups to monitor blood levels. What they fail to note, according to a recent string of lawsuits, is that internal bleeding episodes of warfarin can be stopped with the administration of Vitamin K, while there is no known reversal agent for this occurrence in Xarelto users. Lawsuits over the blood thinner allege episodes of internal bleeding that may be fatal.
In September 2013, it was reported that Germany’s Federal Institute for Drugs and Medical Services received 958 complication reports associated with Xarelto during the first eight months of the year. 72 of those complaints included cases of death. A year earlier, the blood thinner was involved in 750 adverse events, and 58 deaths.
A similar onslaught of Xarelto complaints have been filed in the U.S., according to findings published by the Institute for Safe Medicine Practices. The group’s May 2014 QuarterWatch report showed 680 complication reports during the first quarter of 2013—which was significantly more than those associated with Pradaxa following its U.S. release.
Xarelto Lawsuits Continue to Be Filed in the U.S.
As of October 2014, court records show 21 Xarelto lawsuits filed in the U.S. on behalf of patients who allege life-threatening episodes of internal bleeding and other side effects caused by the medication.
So far, no Xarelto class action lawsuits have been filed against Johnson & Johnson and Bayer. This may be in the best interest of plaintiffs whose level of drug-related injury may have varied, as recoveries made in these types of claims are often evenly distributed among all individuals involved in it.
Pursue a Xarelto Lawsuit Today
Individuals who suffered injuries caused by Xarelto may be entitled to financial compensation for damages incurred by their injuries, including:
- Medical Bills
- Lost Wages
- Pain and Suffering
- Permanent Disability
- Diminished Quality of Life
- Wrongful Death
Learn more about filing a Xarelto lawsuit today when you contact Bernstein Liebhard LLP. Free, no-obligation case reviews may be obtained by calling .
Chronic Kidney Disease Linked To Proton Pump Inhibitor Use
Financial compensation may be available to individuals diagnosed with serious kidney complications following long-term use of Nexium or other proton pump inhibitors. Several recently-published studies have suggested that extended use of heartburn medications like Nexium, Prilosec and Prevacid may increase the risk of chronic kidney disease and kidney failure. Other renal side effects that may be associated with these medications include acute interstitial nephritis and acute kidney injury. If you suffered any of these complications following treatment with an over-the-counter or prescription proton pump inhibitor, please visit Bernstein Liebhard LLP’s Nexium Lawsuit Center to learn more about your legal options and to obtain a free review of your potential claim.